Cargando…
SLC6 transporter oligomerization
Transporters of the solute carrier 6 (SLC6) family mediate the reuptake of neurotransmitters such as dopamine, norepinephrine, serotonin, GABA, and glycine. SLC6 family members are 12 transmembrane helix‐spanning proteins that operate using the transmembrane sodium gradient for transport. These tran...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247324/ https://www.ncbi.nlm.nih.gov/pubmed/32767560 http://dx.doi.org/10.1111/jnc.15145 |
_version_ | 1783716498886361088 |
---|---|
author | Jayaraman, Kumaresan Das, Anand K. Luethi, Dino Szöllősi, Dániel Schütz, Gerhard J. Reith, Maarten E. A. Sitte, Harald H. Stockner, Thomas |
author_facet | Jayaraman, Kumaresan Das, Anand K. Luethi, Dino Szöllősi, Dániel Schütz, Gerhard J. Reith, Maarten E. A. Sitte, Harald H. Stockner, Thomas |
author_sort | Jayaraman, Kumaresan |
collection | PubMed |
description | Transporters of the solute carrier 6 (SLC6) family mediate the reuptake of neurotransmitters such as dopamine, norepinephrine, serotonin, GABA, and glycine. SLC6 family members are 12 transmembrane helix‐spanning proteins that operate using the transmembrane sodium gradient for transport. These transporters assume various quaternary arrangements ranging from monomers to complex stoichiometries with multiple subunits. Dopamine and serotonin transporter oligomerization has been implicated in trafficking of newly formed proteins from the endoplasmic reticulum to the plasma membrane with a pre‐fixed assembly. Once at the plasma membrane, oligomers are kept fixed in their quaternary assembly by interaction with phosphoinositides. While it remains unclear how oligomer formation precisely affects physiological transporter function, it has been shown that oligomerization supports the activity of release‐type psychostimulants. Most recently, single molecule microscopy experiments unveiled that the stoichiometry differs between individual members of the SLC6 family. The present overview summarizes our understanding of the influence of plasma membrane constituents on transporter oligomerization, describes the known interfaces between protomers and discusses open questions. [Image: see text] |
format | Online Article Text |
id | pubmed-8247324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82473242021-07-02 SLC6 transporter oligomerization Jayaraman, Kumaresan Das, Anand K. Luethi, Dino Szöllősi, Dániel Schütz, Gerhard J. Reith, Maarten E. A. Sitte, Harald H. Stockner, Thomas J Neurochem Review Transporters of the solute carrier 6 (SLC6) family mediate the reuptake of neurotransmitters such as dopamine, norepinephrine, serotonin, GABA, and glycine. SLC6 family members are 12 transmembrane helix‐spanning proteins that operate using the transmembrane sodium gradient for transport. These transporters assume various quaternary arrangements ranging from monomers to complex stoichiometries with multiple subunits. Dopamine and serotonin transporter oligomerization has been implicated in trafficking of newly formed proteins from the endoplasmic reticulum to the plasma membrane with a pre‐fixed assembly. Once at the plasma membrane, oligomers are kept fixed in their quaternary assembly by interaction with phosphoinositides. While it remains unclear how oligomer formation precisely affects physiological transporter function, it has been shown that oligomerization supports the activity of release‐type psychostimulants. Most recently, single molecule microscopy experiments unveiled that the stoichiometry differs between individual members of the SLC6 family. The present overview summarizes our understanding of the influence of plasma membrane constituents on transporter oligomerization, describes the known interfaces between protomers and discusses open questions. [Image: see text] John Wiley and Sons Inc. 2020-08-28 2021-05 /pmc/articles/PMC8247324/ /pubmed/32767560 http://dx.doi.org/10.1111/jnc.15145 Text en © 2020 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Jayaraman, Kumaresan Das, Anand K. Luethi, Dino Szöllősi, Dániel Schütz, Gerhard J. Reith, Maarten E. A. Sitte, Harald H. Stockner, Thomas SLC6 transporter oligomerization |
title | SLC6 transporter oligomerization |
title_full | SLC6 transporter oligomerization |
title_fullStr | SLC6 transporter oligomerization |
title_full_unstemmed | SLC6 transporter oligomerization |
title_short | SLC6 transporter oligomerization |
title_sort | slc6 transporter oligomerization |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247324/ https://www.ncbi.nlm.nih.gov/pubmed/32767560 http://dx.doi.org/10.1111/jnc.15145 |
work_keys_str_mv | AT jayaramankumaresan slc6transporteroligomerization AT dasanandk slc6transporteroligomerization AT luethidino slc6transporteroligomerization AT szollosidaniel slc6transporteroligomerization AT schutzgerhardj slc6transporteroligomerization AT reithmaartenea slc6transporteroligomerization AT sitteharaldh slc6transporteroligomerization AT stocknerthomas slc6transporteroligomerization |